Month: May 2020

INDIANAPOLIS, May 07, 2020 (GLOBE NEWSWIRE) — Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) (“IEA” or the “Company”), a leading infrastructure construction company with renewable energy and specialty civil expertise, today announced its financial results for the quarter ended March 31, 2020.Quarter HighlightsRevenue totaled $358.2 million, an increase of 88.7% as compared to the prior-year period.Gross margin of 9.2%, as compared to 3.0% over the prior-year period.Backlog of $2.0 billion provides strong visibility.Cash and cash equivalents of $58.1 million at March 31, 2020 and no long-term debt amortization payments due until 2022.To date, the Company has had no negative material impact from COVID-19 and is reiterating its current 2020 revenue and Adjusted EBITDA guidance.Management Commentary“IEA is considered a provider...

CALGARY, Alberta, May 07, 2020 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX:EFX) (“Enerflex” or “the Company” or “we” or “our”), a leading supplier of products and services to the global energy industry, today reported its financial and operating results for the three months ended March 31, 2020.“While continuing to prioritize the health and safety of our employees, clients and suppliers, we are proud to say that all of Enerflex’s manufacturing facilities, rental, BOOM, and Service operations are open and have been operational since the beginning of the COVID-19 pandemic. Throughout these challenging times, Enerflex employees have kept natural gas, natural gas liquids, and electricity flowing for the benefit of our clients,” said Marc Rossiter, Enerflex’s President and Chief Executive Officer. “Enerflex is a highly globalized company that...

(all amounts in US dollars, unless otherwise noted)VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — Ero Copper Corp. (the “Company”) (TSX: ERO) today is pleased to announce its financial results for the three months ended March 31, 2020. Management will host a conference call tomorrow, Friday, May 8, 2020, at 11:30 a.m. Eastern to discuss the results.  Dial-in details for the call can be found near the end of this press release.HIGHLIGHTSFirst quarter copper production of 10,657 tonnes of copper;Record C1 cash costs* of $0.71 per pound of copper produced contributing to record quarterly cash flow from operations of $37.3 million during the three month period ended March 31, 2020;First quarter gold and silver production at the NX Gold Mine of 7,866 ounces of gold and 4,868 ounces of silver at C1 cash costs* of $594 per...

STAMFORD, Conn., May 07, 2020 (GLOBE NEWSWIRE) — Independence Holding Company (NYSE: IHC) today reported 2020 first-quarter results.   Financial ResultsNet income attributable to IHC per share was $.29 per share, diluted, or $4,278,000, for the three months ended March 31, 2020 compared to $.58 per share, diluted, or $8,727,000, for the three months ended March 31, 2019.  Net income for this quarter is lower primarily because (i) the 2019 first quarter includes a pre-tax gain of $3.6 million on the sale of an equity method investment and (ii) of expenses incurred in the first quarter of this year related to the ramp up of our senior marketing division.The Company reported revenues of $103,997,000 for the three months ended March 31, 2020 compared to revenues for the three months ended March 31, 2019 of $94,182,000.Chief Executive...

HOUSTON, May 07, 2020 (GLOBE NEWSWIRE) — Penn Virginia Corporation (“Penn Virginia” or the “Company”) (NASDAQ:PVAC) today announced its financial and operational results for the first quarter 2020.Recent Significant HighlightsGenerated net cash provided by operating activities of $72.5 million and free cash flow (“FCF”)(1) of $10.5 million for the first quarter of 2020 and expects to generate significant FCF(1) for 2020;Produced 20,665 barrels of oil per day (“BOPD”) and 26,740 barrels of oil equivalent per day (“BOEPD”) in the first quarter of 2020;Reported net income of $163.1 million, or $10.76 per diluted share, and adjusted net income(2) of $28.6 million, or $1.89 per diluted share, for the first quarter of 2020;Generated adjusted EBITDAX(3) of $78.6 million for the first quarter of 2020;Halted all drilling and completion activity...

TAMPA, FL, May 07, 2020 (GLOBE NEWSWIRE) — Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, announced today that its wholly-owned subsidiary, Integra Pharma Solutions, LLC, has formally withdrawn its Emergency Use Authorization (EUA) application in connection with its partner’s manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit from consideration in response to U.S. Food and Drug Administration (FDA) guidance. The decision to withdraw the EUA application was made after much discussion with its partnered manufacturer. Per FDA guidance, only one EUA application is allowed per manufactured kit product. The EUA process is typically filed by manufacturers and there are specific guidelines that must be adhered to by the manufacturer, one of which includes reporting on test...

Le premier patient a été traité dans l’étude VIITAL™ pivot de phase 3 en cours évaluant l’EB-101 pour le pour l’EBDRDes patients supplémentaires ont reçu des doses dans les études de thérapie génique de phase 1/2 sur le MPS IIIA et le MPS IIIBDes données intermédiaires positives issues des programmes de thérapie génique portant sur le MPS III ont été présentées lors du WORLDSymposium™ ; des résultats actualisés seront présentés lors de l’ASGCT 2020Deux chefs de file du secteur ont été nommés au sein du Conseil d’administration et l’équipe de direction a été renforcéeLa société organisera une conférence téléphonique pour les investisseurs le jeudi 7 mai 2020 à 8 h 30 HNENEW YORK et CLEVELAND, 07 mai 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq : ABEO), leader entièrement intégré de...

Behandlung des ersten Patienten im Rahmen der laufenden zulassungsrelevanten VIITAL™-Phase-III-Studie zur Untersuchung von EB-101 für RDEBWeitere Patienten in den Phase-I/II-Gentherapiestudien für MPS IIIA und MPS IIIB behandeltPositive Interimsdaten aus den MPS III-Gentherapieprogrammen auf dem WORLDSymposium™ vorgestellt; aktualisierte Ergebnisse werden auf dem diesjährigen Meeting der ASGCT präsentiertErnennung von zwei Führungskräften der Branche zu Verwaltungsratsmitgliedern und Stärkung des ManagementteamsUnternehmen führt am Donnerstag, den 7. Mai 2020, um 8:30 Uhr ET eine Investorenkonferenz durchNEW YORK und CLEVELAND, May 07, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), ein voll integriertes führendes Unternehmen im Bereich Gen- und Zelltherapien, gab heute die Geschäftsergebnisse des ersten Quartals...